Jonae R. Barnes
Investor Relations Contact at ATEA PHARMACEUTICALS, INC.
Jonae R. Barnes active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Investor Relations Contact | 2021-01-18 | - |
| Public Communications Contact | 2021-01-18 | - |
Career history of Jonae R. Barnes
Former positions of Jonae R. Barnes
| Companies | Position | Start | End |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Investor Relations Contact | 2006-12-31 | 2009-11-30 |
| Public Communications Contact | 2006-12-31 | 2009-11-30 | |
| POXEL | Investor Relations Contact | 2016-03-13 | - |
| Public Communications Contact | 2016-03-13 | - | |
| AGENUS INC. | Investor Relations Contact | 2010-12-31 | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | - | - |
| Public Communications Contact | 2010-10-28 | - |
Training of Jonae R. Barnes
| Suffolk University | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistics
International
| United States | 6 |
| Israel | 2 |
| France | 2 |
Operational
| Investor Relations Contact | 5 |
| Public Communications Contact | 4 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| POXEL | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jonae R. Barnes
- Experience
